Acute and chronic animal models for the evaluation of anti-diabetic agents

King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998, 21: 1414-1431. 10.2337/diacare.21.9.1414. Amos AF, McCarty DJ, Zimmet P: The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997, 14 (5): 1-85. IDF Diabetes Atlas. 2009, International Diabetes Federation, 4 Mohan V, Pradeepa R: Epidemiology of diabetes in different regions of India. Health Administrator. 2009, 22: 1-18. Rother KI: Diabetes treatment--bridging the divide". The New England Journal of Medicine. 2007, 356 (15): 1499-501. 10.1056/NEJMp078030. Other types of diabetes. 2005, American Diabetes Association Handelsman Yehuda MD: A Doctor's Diagnosis: Prediabetes. Power of Prevention. 2009, 1 (2): 1. "Diseases: Johns Hopkins Autoimmune Disease Research Center". Retrieved 2007-09-23 World Health Organisation. Department of Noncommunicable Disease Surveillance: 1999, "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications" Potenza MA, Nacci C, Gagliardi S, Montagnani M: Cardiovascular complications in diabetes: lessons from animal models. Curr Med Chem. 2011, 18: 1806-19. 10.2174/092986711795496755. Rastellini C, Shapiro R, Corry R, Fung JJ, Starzl TE, Rao AS: An attempt to reverse diabetes by delayed islet cell transplantation in Humans. Transplantation. 1997, 29: 2238-2239. Rydgren T, Vaarala O, Sandler S: Simvastatin protects against multiple low dose streptozotocin in-duced type 1 diabetes in CD-1 mice and recurrence of the disease in nonobese diabetic mice. J Pharma-col Expt Ther. 2007, 23: 180-185. Balamurugan AN, Miyamoto M, Wang W, Inoue K, Tabata Y: Streptozotocin (STZ) used to in-duce diabetes in animal models. J Ethnopharm. 2003, 26: 102-103. Hayashi K, Kojima R, Ito M: Strain differences in the diabetogenic activity of streptozotocin in mice. Biol Pharmaceut Bull. 2006, 29: 1110-1119. 10.1248/bpb.29.1110. Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001, 50: 537-46. Takeshita F, Kodama M, Yamamoto H, Ikarashi Y, Ueda S, Teratani T, Yamamoto Y, Tamatani T, Kanegasaki S, Ochiya T, Quinn G: Streptozotocin-induced partial beta cell depletion in nude mice without hyperglycaemia induces pancreatic morphogenesis in transplanted embryonic stem cells. Diabetologia. 2006, 49: 2948-58. 10.1007/s00125-006-0432-z. Weiss RB: Streptozotocin: A review of its pharmacology, efficacy and toxicity. Canc Treat Rep. 1982, 66: 427-438. Brosky G, Logothetopoulos J: Streptozotocin diabetes in the mouse and guinea pig. Diabetes. 1969, 8: 606-611. Ito M: New model of progressive non-insulin-dependent diabetes mellitus in mice induced by Streptozotocin. Biol Pharmaceut Bull. 1999, 22: 988-989. 10.1248/bpb.22.988. Ikebukuro K, Adachi Y, Yamada Y, Fujimoto S, Seino Y, Oyaizu H: Treatment of Streptozotocin-induced diabetes mellitus by transplantation of islet cells Plus bone Marrow cells via portal vein in rats. Transplantation. 2002, 73: 512-518. 10.1097/00007890-200202270-00004. Smith SB, Prior RL, Mersmann HJ: Interrelationship between insulin and lipid metabolism in normal and alloxan-diabetic cattle. J Nutr. 1983, 113: 1002-1015. Viana GS, Medeiros AC, Lacerda AM, Leal LK, Vale TG, Matos FJ: Hypoglycemic and anti-lipidemic effects of the aqueous extract of Cissus si-cyoides. BMC Pharmacol. 2004, 8: 4-9. Szkudelski T: The mechanism of alloxan and streptozotocin action β cells of the rat pancreas. Physiology Res. 2001, 50: 536-546. Bartosikova L, Nieces J, Succhy V, Kubinov R, Vesa-la D, Benes L: Monitoring of antoxidative effect of morine in alloxan-induced diabetes mellitus in the laboratory rat. Acta Vet Bull. 2003, 72: 191-200. 10.2754/avb200372020191. Takasu N, Asawa T, Komiya I, Nagasawa Y, Yama-da T: Alloxan induced DNA strand breaks in pancreatic islets. Journal of Biochemistry. 1991, 266: 2112-2114. Masiello P: Animal models of type11 diabetes with reduced pancreatic β-cell mass. The interna-tional Journal of Biochemistry and Cell Biology. 2006, 38: 873-893. 10.1016/j.biocel.2005.09.007. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002, 48: 436-472. Nathan DM, Turgeon H, Regans S: Relationship between Glycated haemoglobin levels and mean glucose levels over time. Diabetologia. 2007, 50: 2239-2244. 10.1007/s00125-007-0803-0. Barrett-Connor E, Wingard DL: Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol. 1983, 118: 489-96. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program Diabetes. 1987, 36: 689-92. Harris Ml, Entmacher PS: Mortality from diabetes. Edited by: Harris Ml, Hamman RF. 1985, Diabetes in America. U.S. Government Printing Office, NIH, 1-48. Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR: Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care. 1992, 15: 960-967. 10.2337/diacare.15.8.960. Vogel HG, Vogel WH: Drug discovery and evaluation: pharmacological assays. 2002, Springer-Verlag Berlin Heidelberg, New York, 948-1051. Herling AW: Antidiabetic activity Banting FG, Best CH: The internal secretion of the pancreas. J Lab Clin Med. 1922, 7: 251-266. Foa PP: Pankreatektomie. Dörzbach Handbook of experimental Pharmacology. 1971, Insulin, Springer-Verlag, Berlin Heidelberg New York, 32/1: 146-158. Sirek A: Pancreatectomy and diabetes. Handbook of Diabetes mellitus, Pathophysiology and clinical Considerations. Edited by: Pfeiffer EF. 1968, Lehmanns Verlag, München, I: 727-743. Frerichs H, Creutzfeldt W: Der experimentelle chemische Diabetes. Handbook of Experimental Pharmacology. Edited by: Dörzbach E. 1971, Insulin, Springer-Verlag, Berlin Heidelberg New York, 32/1: 159-202. Tasaka Y, Inoue Y, Matsumoto H, Hirata Y: Changes in plasma glucagon, pancreatic polypeptide and insulin during development of alloxan diabetes mellitus in dog. Endocrinol Japon. 1988, 35: 399-40. 10.1507/endocrj1954.35.399. Baily CC, Baily OT: Production of diabetes mellitus inrabbits with alloxan. A preliminary report. J Am Med. 1943, 122: 1165-1166. Goldner MG, Gomori G: Studies on the mechanism of alloxan diabetes. Endocrinology. 1944, 35: 241-248. 10.1210/endo-35-4-241. Frerichs H, Creutzfeldt W: Diabetes durch Beta-Zytotoxine. Handbook of Diabetes mellitus, Pathophysiology and Clinical Considerations. Edited by: Pfeiffer EF. 1968, LehmannsVerlag, München, I: 811-840. Maske H, Weinges K: Untersuchungen über das Verhalten der Meerschweinchen gegenüber verschiedenen diabetogenen Noxen. Alloxan und Dithizon. Naunyn-Schmiedeberg's Arch exper Path Pharmakol. 1957, 230: 406-420. Bänder A, Pfaff W, Schmidt FH, Stork H, Schröder HG: Zur Pharmakologie von HB 419, einem neuen, starwirksamenoralen Antidiabeticum. Arzneim Forsch Drug Res. 1969, 19: 1363-1372. Katsumata K, Katsumata Y, Ozawa T, Katsumata JR: Potentiating effect of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats. Horm Metab Res. 1993, 25: 125-126. 10.1055/s-2007-1002058. Geisen K: Special pharmacology of the new sulfonylurea glimepiride. Arzneim Forsch Drug Res. 1988, 38: 1120-1130. Kodoma T, Iwase M, Nunoi K, Maki Y, Yoshinari M, Fujishima M: A new diabetes model induced by neonatal alloxan treatment in rats. Diab Res Clin Pract. 1993, 20: 183-189. 10.1016/0168-8227(93)90076-H. Rakieten N, Rakieten ML, Nadkarni MV: Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep. 1963, 29: 91-102. Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Jishage K-I, Watanabe T, Sugimoto T, Nakagama H, Sugimura T: Poly(ADP-ribose)polymerase gene disruptionconferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci. 1998, 2301-2304. 96 Cotes PM, Reid E, Young FG: Diabetogenic action of pure anterior pituitary growth hormone. Nature. 1949, 164: 209-211. 10.1038/164209a0. Young FG: Growth and diabetes in normal animals treated with pituitary (anterior lobe) diabetogenic extract. Biochem J. 1941, 39: 515-536. Ingle DJ: The production of glycosuria in the normal rat by means of 17-hydroxy-11-dehydrocorticosterone. Endocrinology. 1941, 29: 649-652. Abelove WA, Paschkis KE: Comparison of the diabetogenic action of cortisone and growth hormone in different species. Endocrinology. 1994, 55: 637-654. Ingle DJ, Li CH, Evans HM: The effect of adrenocorticotropic hormone on the urinary excretion of sodium, chloride, potassium, nitrogen and glucose in normal rats. Endocrinology. 1946, 39: 32-39. 10.1210/endo-39-1-32. Craighead J: Current views on the etiology of insulin-dependent diabetes mellitus. New Engl J Med. 1978, 299: 1439-1445. 10.1056/NEJM197812282992605. Vialettes B, Baume D, Charpin C, De Maeyer-Guignard J, Vague P: Assessment of viral and immune factors in EMC virus- induced diabetes: effects of cyclosporin A and interferon. J Lab Clin Immunol. 1983, 10: 35-40. Hansen WA, Christie MR, Kahn R, Norgard A, Abel I, Petersen AM, Jorgensen DW, Baekkeskov S, Nielsen JH, Lernmark A, Egeberg J, Richter-Olesen H, Grainger T, Kristensen JK, Brynitz S, Bilde T: Supravital dithizone staining in the isolation of human and rat pancreatic islets. Diabetes Res. 1989, 10: 53-57. Heydrick SJ, Gautier N, Olichon-Berte C, Van Obberghen E, Le Marchand Brustel Y: Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am J Physiol Endocrinol Metab. 1995, 268: 604-612. Sartin JL, Lamperti AA, Kemppainen RJ: Alterations in insulin and glucagon secretion by monosodium glutamate lesions of the hypothalamic arcuate nucleus. Endocr Res. 1985, 11: 145-155. Goldberg ED, Eshchenko VA, Bovt VD: The diabetogenic and acidotropic effects of chelators. Exp Pathol. 1991, 42: 59-64. 10.1016/S0232-1513(11)80038-1. Wright PH: Experimental insulin-deficiency due to insulin antibodies. Handbook of Diabetes mellitus, Pathophysiology and Clinical Considerations. Edited by: Pfeiffer EF. 1968, Lehmanns Verlag, München, I: 841-865. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JF: Positional cloning of the mouse obese gene and its human homologue. Nature. 1994, 372: 425-432. 10.1038/372425a0. Friedman JF, Halaas JL: Leptin and the regulation of body weight in mammals. Nature. 1998, 395: 763-770. 10.1038/27376. Ellerman K, Wroblewski M, Rabinovitch A, Like A: Natural killer cell depletion and diabetes mellitus in the BB/Wor rat. Diabetologia. 1993, 36: 596-601. 10.1007/BF00404067. Hao L, Chan SM, Lafferty KJ: Mycophenolate mofetil can prevent the development of diabetes in BB rats. Ann NY Acad Sci. 1993, 969: 328-332. Klöting I, Vogt L: BB/O(TTAWA)K(ARLSBURG) rats:features of a subline of diabetes prone BB rats. Diabetes Res. 1991, 18: 79-87. Yagihashi S, Wada RI, Kamijo M, Nagai K: Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes. Lab Invest. 1993, 68: 296-307. Cohen AM, Teitelbaum A, Saliternik R: Genetics and diet as factors in the development of diabetes mellitus. Metabolism. 1972, 21: 235-240. 10.1016/0026-0495(72)90046-7. Velasquez MT, Kimmel PL, Michaelis OE: Animal models of spontaneous diabetic kidney disease. FASEB J. 1972, 4: 2850-2859. Begum N, Ragiola L: Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats. Metabolisms. 1998, 47: 54-62. 10.1016/S0026-0495(98)90193-7. Zucker LM: Hereditary obesity in the rat associated with hyperlipidemia. Ann NY Acad Sci. 1965, 131: 447-458. 10.1111/j.1749-6632.1965.tb34810.x. Galante P, Maerker E, Scholz R, Rett K, Herberg L, Mosthaf L, Häring HU: Insulin-induced translocation of GLUT 4 in skeletal muscle of insulin-resistant Zucker rats. Diabetologia. 1994, 37: 3-9. 10.1007/BF00428770. Peterson RG, Shaw WN, Neel M-AN, Little LA, Eicheberg J: Zucker Diabetic Fatty rat as a model for non-insulindependent diabetes mellitus. ILAR News. 1990, 32: 16-19. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH: β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocytes-β-cell relationships. Proc Natl Acad Sci. 1994, 91: 10878-10882. 10.1073/pnas.91.23.10878. Velasquez MT, Kimmel PL, Michaelis OE: Animal models of spontaneous diabetic kidney disease. FASEB J. 1990, 4: 2850-2859. Ishida K, Mizuno A, Sano T, Shima K: Which is the primary etiologic event in Otsuka Long-Evans Tokushima fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion?. Metabolism. 1995, 44: 940-945. 10.1016/0026-0495(95)90249-X. Tarrés MC, Martínez SM, Liborio MM, Rabasa SL: Diabetes mellitus en una línea endocrinada de rata. Mendeliana. 1981, 5: 39-48. Dumm CLAG, Semino MC, Gagliardino JJ: Sequential changes in pancreatic islets of spontaneously diabetic rats. Pancreas. 1990, 5: 533-539. 10.1097/00006676-199009000-00007. Koletsky S: Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol. 1975, 80: 129-142. Russell JC, Graham S, Hameed M: Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism. 1994, 43: 538-543. 10.1016/0026-0495(94)90192-9. Friedman JE, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, Kaung HL, Ernsberger P: Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol Endocrinol Metab. 1997, 273: E1014-1023. Adamo M, Shemer J, Aridor M, Dixon J, Carswell N, Bhathena SJ, Michaelis OE, LeRoith D: Liver insulin receptor tyrosine kinase activity in a model of type II diabetes mellitus and obesity. J Nutr. 1989, 119: 484-489. Velasquez MT, Kimmel PL, Michaelis OE: Animal models of spontaneous diabetic kidney disease. FASEB J. 1990, 4: 2850-2859. Nakamura M, Yamada K: Studies on a diabetic (KK) strain of the mouse. Diabetologia. 1967, 3: 212-221. 10.1007/BF01222198. Iwatsuka H, Shino A, Suzouki Z: General survey of diabetic features of yellow KK mice. Endocrinol Japon. 1970, 17: 23-35. 10.1507/endocrj1954.17.23. Diani AR, Sawada GA, Zhang NY, Wyse BM, Connell CL, Vidmar TJ, Connell MA: The KKAy mouse: a model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels. 1987, 24: 297-303. Baeder WL, Sredy J, Sehgal SN, Chang JY, Adams LM: Rapamycin prevents the onset of insulin dependent diabetes mellitus (IDDM) in NOD mice. Clin Exp Immunol. 1992, 89: 174-178. Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni PL: Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol. 1994, 24: 1843-1847. 10.1002/eji.1830240818. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P: Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med. 1997, 186: 1663-1676. 10.1084/jem.186.10.1663. Bleisch VR, Mayer J, Dickie MM: Familial diabetes mellitus in mice associated with insulin resistance, obesity and hyperplasia of the islands of Langerhans. Am J Pathol. 1952, 28: 369-385. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weightreducing effects of the plasma protein encoded by the obesegene. Science. 1995, 269: 543-546. 10.1126/science.7624777. Herberg L, Coleman DL: Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism. 1977, 26: 59-99. 10.1016/0026-0495(77)90128-7. Tartaglia LA, Dembski M, Wenig X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J: Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995, 83: 1263-1271. 10.1016/0092-8674(95)90151-5. Like AA, Lavine RL, Poffenbarger PL, Chick WI: Studies on the diabetic mutant mouse. VI Evolution of glomerular lesions and associated proteinuria. Am J Pathol. 1972, 66: 193-224. Friedman JF, Halaas JL: Leptin and the regulation of body weight in mammals. Nature. 1998, 395: 763-770. 10.1038/27376. Connelly DM, Taberner PV: Characterization of spontaneous diabetes obesity syndrome in mature CBA/Ca mice. Pharmacol Biochem Behav. 1989, 34: 255-259. 10.1016/0091-3057(89)90308-0. Jones E: Spontaneous hyperplasia of the pancreatic islets associated with glycosuria in hybrid mice. The structure and metabolism of pancreatic islets. Edited by: Brolin SE, Hellman B, Knutson H. 1964, Pergamon Press, Oxford, 189-191. Like AA, Jones EE: Studies on experimental diabetes in the Wellesley hybrid mouse. IV. Morphologic changes in islet tissue. Diabetologia. 1967, 3: 179-187. 10.1007/BF01222196. Meier H, Yerganian G: Spontaneous hereditary diabetes mellitus in the Chinese hamster (Cricetulus griseus). III. Maintenance of a diabetic hamster colony with the aid of hypoglycemictherapy. Diabetes. 1961, 10: 19-21. Strasser H: A breeding program for spontaneously diabetic experimental animals.: Psammomys obesus (sand rat) and Acomyscahirinus (spiny mouse). Lab Anim Care. 1968, 18: 328-338. Dubault J, Boulanger M, Espinal J, Marquie G, Petkov P, du Boistesselin R: Latent autoimmune diabetes mellitus in adult humans with non-insulin-dependent diabetes: Is Psammomys obesus a suitable animal model?. Acta Diabetol. 1995, 32: 92-94. 10.1007/BF00569564. Pictet R, Orci L, Gonet AE, Rouiller Ch, Renold AE: Ultrastructural studies of the hyperplastic islets of Langerhans of spiny mice (Acomys cahirinus) before and during the development of hyperglycemia. Diabetologia. 1967, 3: 188-211. 10.1007/BF01222197. Schmidt G, Martin AP, Stuhlman RA, Townsend JF, Lucas FV, Vorbeck ML: Evaluation of hepatic mitochondrial function in the spontaneously diabetic Mystromys albicaudatus. Lab Invest. 1974, 30: 451-457. Wise PH, Weir BJ, Hime JM, Forrest E: The diabetic syndrome in the Tuco-Tuco (Ctenomis talarum). Diabetologia. 1972, 8: 165-172. 10.1007/BF01212256. Howard CF: Basement membrane thickness in muscle capillaries of normal and spontaneously diabetic Macaca nigra. Diabetes. 1975, 24: 201-206. 10.2337/diabetes.24.2.201. Schaefer EM, Viard V, Morin J, Ferré P, Pénicaud L, Ramos P, Maika SD, Ellis L, Hammer RE: A new transgenic mouse model of chronic hyperglycemia. Diabetes. 1994, 43: 143-153. 10.2337/diabetes.43.1.143. Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell IH, Brinster RL: Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell. 1987, 50: 435-443. 10.1016/0092-8674(87)90497-1. Aichele P, Hyburtz D, Ohashi POS, Odermatt B, Zinkernagel , Hengartner H, Pircher H: Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci. 1994, 91: 444-448. 10.1073/pnas.91.2.444. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 1991, 65: 319-331. 10.1016/0092-8674(91)90165-U. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel RM, Hengartner H: Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 1991, 65: 305-317. 10.1016/0092-8674(91)90164-T. Von Herrath MG, Dockter J, Oldstone MBA: How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic mouse model. Immunity. 1994, 1: 231-242. 10.1016/1074-7613(94)90101-5. Von Herrath MG, Holz A: Pathological changes in the islet milieu precede infiltration of islets and destruction in β-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. J Autoimmun. 1997, 10: 231-238. 10.1006/jaut.1997.0131. Moritani M, Yoshimoto K, Ii S, Kondo M, Iwahana H, Yamaoka T, Sano T, Nakano N, Kikutani H, Itakura M: Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes: A gene therapy model of autoimmune diabetes. J Clin Invest. 1996, 98: 1851-1859. 10.1172/JCI118986. Matsumoto Y, Sumiya E, Sugita T, Sekimizu K: An Invertebrate Hyperglycemic Model for the Identification of Anti-Diabetic Drugs. PLoS ONE. 2011, 6 (3): e18292-10.1371/journal.pone.0018292. Higgins PB, Bastarrachea RA, Lopez-Alvarenga JC, Garcia-Forey M, Proffitt JM, Voruganti SV, Tejero ME, Mattern V, Haack K, Shade RE, Cole SA, Comuzzie AG: Eight week exposure to a high sugar high fat diet results in adiposity gain and alterations in metabolic biomarkers in baboons (Papio hamadryas sp.). Cardiovascular Diabetology. 2010, 9: 71-10.1186/1475-2840-9-71.